Centers for Disease Control and Prevention
Division of STD Prevention
1600 Clifton Road
MS E02
Atlanta,
GA
USA
30333
Email:
bwd3@cdc.gov
Biographical Sketch:
Medical Epidemiologist, Centers for Disease Control and Prevention (CDC), 7/06-present
Project Officer, Gonococcal Isolate Surveillance Project (GISP), 7/06- present
EIS Officer, Centers for Disease Control and Prevention (CDC), 6/04-6/06
Division of Viral and Rickettsial Diseases, Respiratory and Enteric Viruses Branch
Relevant publications and presentations:
CDC. Sexually Transmitted Disease Surveillance, 2005. Atlanta, GA: U.S. Department of Health and Human Services, November 2006.
CDC. Sexually Transmitted Disease Surveillance, 2005 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report-2005. Atlanta, GA: U.S. Department of Health and Human Services, January 2007.
Del Rio, C, G Hall, EW Hook, KK Holmes, WLH Whittington, EL Yee, A Harvey, KP Kramer, D Trees, R Ballard, KA Workowski, LM Newman, S Berman, & HS Weinstock. Update to CDC’s Sexually Transmitted Disease Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections. MMWR Weekly. April 13, 2007, 56(14), pgs. 332-336.
CDC. Sexually Transmitted Disease Surveillance, 2006. Atlanta, GA: U.S. Department of Health and Human Services, November 2007. (GISP section only)
CDC. Sexually Transmitted Disease Surveillance, 2006 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report-2006. Atlanta, GA: U.S. Department of Health and Human Services, April 2008.
CDC. Sexually Transmitted Disease Surveillance, 2007. Atlanta, GA: U.S. Department of Health and Human Services, January 2009.
CDC. Sexually Transmitted Disease Surveillance, 2007 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report-2007. Atlanta, GA: U.S. Department of Health and Human Services, March 2009.
CDC. Sexually Transmitted Disease Surveillance, 2008. Atlanta, GA: U.S. Department of Health and Human Services, December 2008.
Discontinuation of Fluoroquinolone Use in the Treatment of Neisseria Gonorrhoeae Infections in the United States, 2007. (Poster) International Society for STD Research (Seattle, WA) August 1, 2007.
Yee EL. Monitoring Emerging Resistance in N. Gonorrhoeae in the U.S. [Abstract 6: Symposium-the Changing Epidemiology of STDs in the United States] 2008 National STD Conference in Chicago, IL, March 11th, 2008.
Yee EL. Multidrug-Resistant Gonorrhea-The GC Isolate Surveillance Program [Concurrent Panel Session J3: Sexually Transmitted Diseases] 2008 International Conference on Emerging Infectious Disease, Atlanta, GA, March 19th, 2008.
Dowell, DR, Peterman T, Newman L, Yee E, and Weinstock H. Evaluation of the Impact of Revised Treatment Recommendations on the Use of Fluoroquinolones for Gonorrhea Treatment-United States, 2007. 57th Epidemic Intelligence Service Conference, Atlanta, Georgia, April 15th, 2008.